PURPOSE: Although fear of recurrence (FCR) is common among cancer survivors, it remains unclear what factors predict initial levels (e.g., prior to surgery) or changes in FCR in the post-treatment period. Among women treated for breast cancer, this study evaluated the effects of demographic, clinical, symptom, and psychosocial adjustment characteristics on the initial (preoperative) levels of FCR and trajectories of FCR over 6 months following surgery. METHODS: Prior to and for 6 months following breast cancer surgery, 396 women were assessed for demographic and clinical (disease and treatment) characteristics, symptoms, psychological adjustment characteristics, and quality of life (QOL). FCR was assessed using a four-item subscale from the QOL instrument. Hierarchical linear modeling was used to examine changes in FCR scores and to identify predictors of inter-individual differences in preoperative FCR levels and trajectories over 6 months. RESULTS: From before surgery to 6 months post-operatively, women with breast cancer showed a high degree of inter-individual variability in FCR. Preoperatively, women who lived with someone, experienced greater changes in spiritual life, had higher state anxiety, had more difficulty coping, or experienced more distress due to diagnosis or distress to family members reported higher FCR scores. Patients who reported better overall physical health and higher FCR scores at enrollment demonstrated a steeper decrease in FCR scores over time. CONCLUSIONS: These findings highlight inter-individual heterogeneity in initial levels and changes in FCR over time among women undergoing breast cancer surgery. Further work is needed to identify and provide interventions for women experiencing FCR during and after breast cancer treatment.
PURPOSE: Although fear of recurrence (FCR) is common among cancer survivors, it remains unclear what factors predict initial levels (e.g., prior to surgery) or changes in FCR in the post-treatment period. Among women treated for breast cancer, this study evaluated the effects of demographic, clinical, symptom, and psychosocial adjustment characteristics on the initial (preoperative) levels of FCR and trajectories of FCR over 6 months following surgery. METHODS: Prior to and for 6 months following breast cancer surgery, 396 women were assessed for demographic and clinical (disease and treatment) characteristics, symptoms, psychological adjustment characteristics, and quality of life (QOL). FCR was assessed using a four-item subscale from the QOL instrument. Hierarchical linear modeling was used to examine changes in FCR scores and to identify predictors of inter-individual differences in preoperative FCR levels and trajectories over 6 months. RESULTS: From before surgery to 6 months post-operatively, women with breast cancer showed a high degree of inter-individual variability in FCR. Preoperatively, women who lived with someone, experienced greater changes in spiritual life, had higher state anxiety, had more difficulty coping, or experienced more distress due to diagnosis or distress to family members reported higher FCR scores. Patients who reported better overall physical health and higher FCR scores at enrollment demonstrated a steeper decrease in FCR scores over time. CONCLUSIONS: These findings highlight inter-individual heterogeneity in initial levels and changes in FCR over time among women undergoing breast cancer surgery. Further work is needed to identify and provide interventions for women experiencing FCR during and after breast cancer treatment.
Authors: Marieke H J van den Beuken-van Everdingen; Janneke M de Rijke; Alfons G Kessels; Harry C Schouten; Maarten van Kleef; Jacob Patijn Journal: J Pain Symptom Manage Date: 2009-06-28 Impact factor: 3.612
Authors: Maria Kyranou; Steven M Paul; Laura B Dunn; Kathleen Puntillo; Bradley E Aouizerat; Gary Abrams; Deborah Hamolsky; Claudia West; John Neuhaus; Bruce Cooper; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2012-08-11 Impact factor: 2.398
Authors: Marilyn J Hammer; Steven M Paul; Amir Steinberg; Patricia Eckardt; Margaret Barton-Burke; Christine Miaskowski Journal: Cancer Nurs Date: 2019 Jul/Aug Impact factor: 2.592
Authors: Janni Leung; Iain Atherton; Richard G Kyle; Gill Hubbard; Deirdre McLaughlin Journal: Support Care Cancer Date: 2015-10-05 Impact factor: 3.603
Authors: Christine Miaskowski; Steven M Paul; Judy Mastick; Gary Abrams; Kimberly Topp; Betty Smoot; Kord M Kober; Margaret Chesney; Melissa Mazor; Grace Mausisa; Mark Schumacher; Yvette P Conley; Jennifer Henderson Sabes; Steven Cheung; Margaret Wallhagen; Jon D Levine Journal: J Pain Symptom Manage Date: 2018-03-07 Impact factor: 3.612
Authors: Marshall Gold; Laura B Dunn; Bethany Phoenix; Steven M Paul; Deborah Hamolsky; Jon D Levine; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2015-07-15 Impact factor: 2.398
Authors: Sharon L Manne; Shannon Myers-Virtue; David Kissane; Melissa L Ozga; Deborah A Kashy; Stephen C Rubin; Norman G Rosenblum; Carolyn J Heckman Journal: Psychooncology Date: 2016-08-09 Impact factor: 3.894
Authors: Melissa Mazor; Steven M Paul; Margaret A Chesney; Lee-May Chen; Betty Smoot; Kimberly Topp; Yvette P Conley; Jon D Levine; Christine Miaskowski Journal: Cancer Date: 2019-09-10 Impact factor: 6.860